CEMIP and inflammatory bowel disease: The consequences of KIAA1199 overexpression during intestinal inflammation have not been clear-cut elucidated yet, although KIAA1199 activation conceivably generates endogenous danger signals in the form of HA fragments that perpetuate and promote inflammation and fibrosis in IBD.